Medicine and Dentistry
Breast Cancer
69%
Neoplasm
47%
Cancer Cell
42%
Malignant Neoplasm
41%
Cancer Testis Antigen
29%
Metastatic Carcinoma
26%
Tamoxifen
26%
Non Small Cell Lung Cancer
23%
Hormone Therapy
21%
Estrogen Receptor
21%
Estrogen Receptor Positive Breast Cancer
17%
Biological Marker
17%
Triple Negative Breast Cancer
15%
Recurrent Disease
15%
Geriatric Assessment
14%
Cancer Therapy
14%
Epidermal Growth Factor Receptor
12%
Gene Expression
12%
Upregulation
12%
Human Monoclonal Antibody
12%
Frailty
12%
Cell Line
12%
CDK4/6 Inhibitor
12%
Gene Expression Profiling
11%
microRNA
11%
Colon Carcinoma
11%
Cancer Stem Cell
10%
Geriatrics
10%
Quality of Life
9%
Primary Tumor
9%
Immunotherapy
9%
Antigen Expression
9%
Cancer Immunotherapy
9%
Small Interfering RNA
8%
Multiple Myeloma
8%
Postmenopause
8%
Randomized Controlled Trial
8%
Oncogene
8%
Lung Cancer
8%
Immunoglobulin M
7%
Tumor Progression
7%
Tumor Cell
7%
Xenograft
7%
Cancer
6%
Metastatic Breast Cancer
6%
In Vitro
6%
Colon Epithelium
6%
Non-Small Cell Lung Cancer
6%
Monoclonal Antibody
6%
Disease
6%
Immunology and Microbiology
Immunology
83%
Cancer Cell
52%
Monoclonal Antibody
28%
Human Monoclonal Antibody
27%
Epitope
27%
Human Immunodeficiency Virus 1
25%
Cancer Testis Antigen
23%
Cell Line
22%
Phage Display
21%
Colon
17%
Cancer Immunotherapy
17%
Gene Expression
17%
Immunity
14%
Immunotherapy
14%
Immunoglobulin M
14%
Tumor Antigen
13%
Tumor Cell
13%
Lymph Node
13%
Autoantibodies
13%
Cell Surface
12%
B Cell
11%
Immunoglobulin F(ab) Fragment
9%
Antibody Response
9%
CD4
9%
T Cell
9%
Germ Cell
9%
Cell Proliferation
8%
Real-Time Polymerase Chain Reaction
8%
Xenograft
8%
Breast Cancer Cell Line
8%
Binding Site
8%
Heavy Chain
7%
Downregulation
7%
Quantitative Reverse Transcription Polymerase Chain Reaction
7%
Testis
7%
Neutralization
6%
Autoantigen
6%
Cancer Cell Line
6%
Antigen Expression
6%
Binding Antibody
6%
Immunoglobulin A
6%
Antineoplastic Activity
6%
Hybridoma
6%
Breast Tissue
6%
Virion
6%
Glucose 6 Phosphate Isomerase
5%
Myeloid-Derived Suppressor Cell
5%
Systemic Lupus Erythematosus
5%
Upregulation
5%
Bispecific Antibody
5%
Biochemistry, Genetics and Molecular Biology
Cancer Cell
100%
Estrogen Receptor
25%
Gene Expression
25%
MicroRNA
22%
Epidermal Growth Factor Receptor
20%
Cancer Stem Cell
16%
Proteomics
16%
SSX2
15%
Cancer Immunotherapy
13%
Fulvestrant
12%
Tumor Progression
12%
HMGA2
11%
Small Interfering RNA
11%
Quantitative Proteomics
10%
Copurification
9%
Cell Proliferation
9%
Epigenetics
9%
Erlotinib
9%
Genomics
9%
Germ Cell
9%
Germline
9%
Cell Membrane
9%
Mesenchymal-Epithelial Transition
8%
Circulating Tumor DNA
8%
Tamsulosin
8%
Overall Survival
8%
Downregulation
8%
Proteome
8%
Signal Transduction
7%
Antigen Expression
7%
P53
7%
Monoclonal Antibody
7%
Transmembrane Protein
7%
Upregulation
7%
Tyrosine Kinase Inhibitor
6%
Carcinogenesis
6%
Cell Surface Marker
6%
Protein Expression
6%
Cell-Cell Interaction
6%
Phosphotransferase
6%
Kinase
6%
Immunity
6%
Colon
6%
Cell-Penetrating Peptide
6%
Myeloid
6%
Oncogene
6%
Mass Spectrometry
5%
Synapsin I
5%
Immunoglobulin M
5%
Disease Free Survival
5%
